July 9, 2007 - The world imaging agents market — including barium and iodine-based agents along with contrast agents and radiopharmaceuticals used with more sophisticated technologies — is expected to reach US$10.4 billion in 2010. "Imaging Agents: A Global Strategic Business Report" attributes the growth to a continued increase in procedural volumes.
The report examines market trends, drivers, challenges, product profiles, competition, regulatory framework, technological developments, R&D activity and much more. Analysis is presented for major geographic markets including the U.S., which is the largest market, Japan, France, Germany, the U.K., Italy, Asia, Latin America and the Middle East.
Leading market participants include Advanced Magnetics, Alliance Pharmaceutical, Amersham, Biomira Inc, Bracco Group, Bristol-Myers Squibb, Cytogen Corp, Daiichi Sankyo Company, Dowpharma, Eisai Co, EPIX Pharmaceutical, E-Z-EM Inc, Guerbet Group, Immunomedics Inc, Schering AG and Tyco Healthcare.
For more information: www.strategyr.com/MCP-3336.asp